🦉 What The Oracle Is Buying—And Selling

Plus, the importance of agility in this market, and more

🥊 How Trump's Reciprocal Tariffs Could Impact The Economy

Plus, the stocks Cathie Wood is buying and selling, and more

❄️ Why The Market Is Feeling The Chill

Plus, pay attention to these insider transactions, and more

💰 Why The Fed Isn’t Ready To Cut Rates—Yet

Plus, uncover compelling but less-heralded stock ideas, and more

🔗 What Tariffs On Metal Imports Could Mean For Your Portfolio

Plus, how to better navigate the new market paradigm, and more

🪠 Why A Short Seller Is Sounding The Alarm

Plus, the stocks that are quietly garnering attention, and more

Bayer-Funded Phase 2 Clinical Study To Test Combination Of RedHill's Opaganib And Bayer’s Darolutamide, In Treatment-Resistant Prostate Cancer

⛈️ Why A Winter Storm Could Wreak Havoc On The Market

Plus, stocks to watch amid the bird flu outbreak, and more

🤑 Here Are The Boss Moves Cathie Wood Just Made

Plus, pay attention to these insider transactions, and more

☕ Why Your Morning Joe Is About To Get More Expensive

Plus, discover unheralded opportunities before the public does, and more

What’s Your Excuse Now?

🤝 Why The U.S.-Canada Standoff Cooled Down

Plus, why the Fed is holding steady, and more